Results 21 to 30 of about 8,862,620 (337)

Transfusion-associated adverse events and implementation of blood safety measures - findings from the 2017 National Blood Collection and Utilization Survey. [PDF]

Transfusion, 2020
Serious transfusion‐associated adverse events are rare in the United States. To enhance blood safety, various measures have been developed. With use of data from the 2017 National Blood Collection and Utilization Survey (NBCUS), we describe the rate of ...
Savinkina AA, Haass KA, Sapiano MRP, Henry RA, Berger JJ, Basavaraju SV, Jones JM.   +6 more
europepmc   +2 more sources

HIV antiretroviral therapy and prevention use in US blood donors: a new blood safety concern.

Blood, 2020
CONTEXT Antiretroviral therapy (ART) to treat and pre-exposure prophylaxis (PrEP) to prevent HIV infection are effective tools to help end the HIV epidemic. However, their use could affect HIV transfusion-transmission risk.
Custer B, Quiner C, Haaland R, Martin A, Stone M, Reik R, Steele WR, Kessler D, Williamson PC, Anderson SA, Williams AE, Raymond HF, McFarland W, Robinson WT, Glick S, Sey K, Melton CD, Glynn SA, Stramer SL, Busch MP.   +19 more
europepmc   +2 more sources

West Nile and Usutu Virus Infections and Challenges to Blood Safety in the European Union. [PDF]

Emerg Infect Dis, 2019
West Nile virus (WNV) and Usutu virus (USUV) circulate in several European Union (EU) countries. The risk of transfusion-transmitted West Nile virus (TT-WNV) has been recognized, and preventive blood safety measures have been implemented.
Domanović D, Gossner CM, Lieshout-Krikke R, Mayr W, Baroti-Toth K, Dobrota AM, Escoval MA, Henseler O, Jungbauer C, Liumbruno G, Oyonarte S, Politis C, Sandid I, Vidović MS, Young JJ, Ushiro-Lumb I, Nowotny N.   +16 more
europepmc   +2 more sources

Analysis of HLA allele-specific antibodies and Eplets in patients with platelet transfusion refractoriness

Zhongguo shuxue zazhi, 2022
Objective To analyze the specificity and Eplets of HLA allele-specific antibody in patients with platelet transfusion refractoriness (PTR). Methods HLA-A and B genotypes were detected by PCR-SBT, and HLA-Ⅰ antibodies in patients′ serum were detected by ...
Bing ZHANG, Xinyu HUANG, Ying LIU, Gang XU, Shu CHEN, Xianguo XU, Faming ZHU   +6 more
doaj   +1 more source

A case of McLeod syndrome caused by a nonsense variation c.942G>A in the XK gene: A case report

Frontiers in Genetics, 2023
McLeod syndrome is a rare XK gene-related progressive, debilitating disease involving multiple systems. The blood group phenotypes in McLeod syndrome patients usually display the Kx antigen loss and a decrease in the Kell blood group system antigen ...
Yanling Ying, Yanling Ying, Shifang Yu, Jingjing Zhang, Jingjing Zhang, Ji He, Ji He, Xianguo Xu, Xianguo Xu, Xiaozhen Hong, Xiaozhen Hong, Faming Zhu, Faming Zhu   +12 more
doaj   +1 more source

The Significance of RHD Genotyping and Characteristic Analysis in Chinese RhD Variant Individuals

Frontiers in Immunology, 2021
BackgroundRhD is the most important and complex blood group system because of its highly polymorphic and immunogenic nature. RhD variants can induce immune response by allogeneic transfusion, organ transplantation, and fetal immunity.
Yanling Ying, Yanling Ying, Jingjing Zhang, Jingjing Zhang, Xiaozhen Hong, Xiaozhen Hong, Xianguo Xu, Xianguo Xu, Ji He, Ji He, Faming Zhu, Faming Zhu   +11 more
doaj   +1 more source

Plasma metagenomics reveals regional variations of emerging and re-emerging pathogens in Chinese blood donors with an emphasis on human parvovirus B19

One Health, 2023
At present, many infectious pathogens, especially emerging/re-emerging pathogens, exist in the blood of voluntary blood donors and may be transmitted through blood transfusions.
Zhao Mengyi, Li Yuhui, Gao Zhan, Liu Anqing, Li Yujia, Li Shilin, Gao Lei, Lan Yue, Huang Mei, Wan Jianhua, He Weilan, Mao Wei, Cai Jie, Zhou Jingyu, Yin Yijing, Guo Yanli, Zhong Qiulei, Huang Yang, Chen Limin, Fan Zhenxin, He Miao   +20 more
doaj   +1 more source

Simultaneous genotyping for human platelet antigen systems and HLA-A and HLA-B loci by targeted next-generation sequencing

Frontiers in Immunology, 2022
In order to treat the alloimmunization platelet transfusion refractoriness (PTR), human leukocyte antigen (HLA)-type and/or human platelet antigen (HPA)-type matched platelets between donors and patients are usually used.
Jielin Wang, Jielin Wang, Xuan You, Xuan You, Yanmin He, Yanmin He, Xiaozhen Hong, Xiaozhen Hong, Ji He, Ji He, Sudan Tao, Sudan Tao, Faming Zhu, Faming Zhu   +13 more
doaj   +1 more source

Health technology assessment of pathogen reduction technologies applied to plasma for clinical use [PDF]

, 2016
Although existing clinical evidence shows that the transfusion of blood components is becoming increasingly safe, the risk of transmission of known and unknown pathogens, new pathogens or re-emerging pathogens still persists.
Berrino, Alexandra, Casini, Marina, Cicchetti, Americo, Codella, Paola, Facco, Giuseppina, Fiore, Alessandra, Grazzini, Giuliano, Liumbruno, Giancarlo M., Marano, Giuseppe, Marchetti, Marco, Midolo, Emanuela, Minacori, Roberta, Refolo, Pietro, Romano, Federica, Ruggeri, Matteo, Sacchini, Dario, Spagnolo, Antonio G., Urbina, Irene, Vaglio, Stefania   +18 more
core   +1 more source

One Health approach for West Nile virus surveillance in the European Union: relevance of equine data for blood safety. [PDF]

Euro Surveill, 2019
West Nile virus (WNV) infection is notifiable in humans and equids in the European Union (EU). An area where a human case is detected is considered affected until the end of the mosquito transmission season (week 48) and blood safety measures have to be ...
Young JJ, Coulombier D, Domanović D, European Union West Nile fever working group, Zeller H, Gossner CM.   +5 more
europepmc   +2 more sources